Unilabs York Bioanalytical Solutions
Private Company
Funding information not available
Overview
Unilabs York Bioanalytical Solutions is a UK-based, service-focused CRO with over 25 years of industry experience, specializing in bioanalysis, biomarkers, and metabolism studies for drug development. It leverages advanced analytical technologies like LC-MS/MS and immunoassays, supported by robust quality assurance systems and regulatory compliance (MHRA, FDA, DKMA). The company caters to a global clientele of pharma and biotech firms, providing critical data to accelerate therapeutic programs from early discovery to commercialization.
Technology Platform
Integrated bioanalytical platform utilizing LC-MS/MS, UPLC, and immunoassay instrumentation for small and large molecule analysis, supported by specialized LIMS (Watson, ClinAxys) and electronic notebook systems (Labnotes) for data management and high QA oversight.
Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded CRO market competing against large global players (e.g., LabCorp, IQVIA) and many specialized boutique labs. Differentiates through a strong focus on technical complexity (e.g., unstable metabolites, peptides), high QA standards, and a partnership-oriented approach to client service.